SARS-CoV-2-IN-8

SARS-CoV-2-IN-8

• UNSPSC Description: SARS-CoV-2-IN-8 is a SARS-CoV-2 main protease inhibitor with an IC50 value of 0.75 μM.
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-in-8.html
• Solubility: 10 mM in DMSO
• Smiles: O=C(N(C1)CC(C(O)C1(C)C2)(C)CN2C(C3=NN(C)C4=C3CCC5=C4C=CC=C5)=O)C6=NN(C)C7=C6CCC8=C7C=CC=C8
• Molecular Weight: 590.71
• References & Citations: [1]Shcherbakov D, et al. Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors. ACS Med. Chem. Lett. 2021.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported